Medical and pediatric oncology

publication venue for

Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification. 2003
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. 2001
Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. 2001
Spontaneous remission of congenital acute nonlymphoblastic leukemia with normal karyotype in twins. 2000
Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis. 1999
Primary subconjunctival lymphoma: an unusual presentation of childhood non-Hodgkin's lymphoma. 1991
Splenectomy after angiographic embolization of the splenic artery in patients with massive splenomegaly and severe thrombocytopenia, in juvenile subacute myelomonocytic leukemia. 1984
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience.. 41. 2003
Impact on survivors of retinoblastoma when informed of study results on risk of second cancers.. 41. 2003
Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers.. 40. 2003
Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor.. 39. 2002
Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.. 38. 2002
Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors.. 38. 2002
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.. 37. 2001
Benign outcome of RSV infection in children with cancer.. 37. 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.. 36. 2001
Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.. 36. 2001
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.. 36. 2001
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.. 36. 2001
Correlation of anti-idiotype network with survival following anti-G(D2) monoclonal antibody 3F8 therapy of stage 4 neuroblastoma.. 35. 2000
Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro.. 35. 2000
Laser-capture microdissected schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations.. 35. 2000
Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma.. 35. 2000
Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma.. 35. 2000
Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.. 35. 2000
Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.. 35. 2000
Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation.. 35. 2000
P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines.. 35. 2000
Clinically critical impact of molecular genetic studies in pediatric solid tumors.. 33. 1999
Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma.. 33. 1999
Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group.. 33. 1999
Gonadal function in young patients successfully treated for Hodgkin disease.. 32. 1999
Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?. 32. 1999
Brain abscesses in children with cancer.. 31. 1998
High-dose rate intraoperative radiation therapy for pediatric solid tumors.. 30. 1998
Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: the Memorial Sloan-Kettering experience.. 30. 1998
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.. 27. 1996
Pulmonary function in children treated for rhabdomyosarcoma.. 27. 1996
Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients.. 24. 1995
Combination trial of subcutaneous recombinant alpha 2 b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma.. 22. 1994
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study Group.. 20. 1992
Primary skeletal non-Hodgkin's lymphoma in the pediatric age group.. 20. 1992
Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.. 19. 1991
Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study.. 19. 1991
Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro.. 18. 1990
Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.. 18. 1990
Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin's disease: a CALGB study.. 18. 1990
Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma.. 18. 1990
Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patients.. 12. 1984
Administration of a complex chemotherapy regimen: inpatient versus outpatient treatment.. 11. 1983
Ovarian function after successful bone marrow transplantation in postmenarcheal females.. 11. 1983
Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia.. 11. 1983
Acute promyelocytic leukemia in children.. 9. 1981
Cardiac changes with cyclophosphamide.. 9. 1981
Cloning of fresh lymphoma cells.. 9. 1981
Phase I trial of rubidazone (NSC 164011) in children with cancer.. 9. 1981
A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia.. 6. 1979
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up study.. 6. 1979
Granulocyte transfusions in infected neutropenic children with malignancies.. 6. 1979
Role of peritoneoscopy in the postoperative evaluation and treatment of adenocarcinoma of the exocrine pancreas.. 6. 1979
Chemotherapy of head and neck cancer: combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin.. 3. 1977
Cell kill kinetics with hydroxyurea.. 2. 1976
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma.. 1. 1975
Reproductive physiology and treatment-related loss of sex hormone production. 1999
Reproductive technologies 1998: options available for the cancer patient. 1999
Acute myeloblastic leukemia following non-Hodgkin lymphoma in an adolescent. A report of a case with preleukemic syndrome, and review of the literature. 1981

VIVO Weill Cornell Medical College

Medical and pediatric oncology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)